1. Predictive value of TP53 fluorescence in situ hybridization in cytogenetic subgroups of acute myeloid leukemia.
- Author
-
Tavor, Sigal, Rothman, Rachel, Golan, Tamar, Voskoboinik, Nadia, Katz, Ben-Zion, Sarid, Nadav, Shomrat, Ruth, Orr-Urtreger, Avi, and Naparstek, Elizabeth
- Subjects
ACUTE myeloid leukemia diagnosis ,KARYOTYPES ,DIAGNOSTIC use of fluorescence in situ hybridization ,CHROMOSOME abnormalities ,DRUG therapy ,PROGNOSIS - Abstract
Acute myeloid leukemia (AML) with a complex karyotype (CK) has frequent alterations in TP53 and a very poor prognosis. We examined whether a prompt and simple fluorescence in situ hybridization (FISH) analysis for 17p13 deletion at diagnosis has a predictive value for response to therapy and overall survival in subgroups of AML. In 15 patients with a normal karyotype the TP53 FISH analysis was normal, whereas in 16 patients with CK 75%% had only one copy of the TP53 allele. The deletion was also detected in 33%% of six patients with monosomy or partial monosomy of chromosome 5, 7, 9, or 12. This loss of TP53 correlated significantly with a poor response to chemotherapy, and the median survival time of these patients was shorter. TP53 FISH analysis carried out at diagnosis has a predictive value with respect to chemotherapy response and can therefore facilitate a rapid decision on treatment strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF